Uranium
Compare Stocks
5 / 10Stock Comparison
CCJ vs XOM vs NEE vs CVX vs COP
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Regulated Electric
Oil & Gas Integrated
Oil & Gas Exploration & Production
CCJ vs XOM vs NEE vs CVX vs COP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Uranium | Oil & Gas Integrated | Regulated Electric | Oil & Gas Integrated | Oil & Gas Exploration & Production |
| Market Cap | $51.67B | $620.85B | $194.60B | $364.18B | $140.02B |
| Revenue (TTM) | $3.48B | $323.90B | $27.93B | $184.43B | $58.31B |
| Net Income (TTM) | $589M | $28.84B | $8.18B | $12.30B | $7.32B |
| Gross Margin | 29.4% | 21.7% | 47.8% | 30.4% | 29.2% |
| Operating Margin | 17.5% | 10.5% | 29.5% | 9.0% | 18.3% |
| Forward P/E | 74.0x | 14.8x | 23.1x | 15.0x | 13.3x |
| Total Debt | $1.02B | $43.54B | $95.62B | $46.74B | $23.44B |
| Cash & Equiv. | $1.11B | $10.68B | $2.81B | $6.47B | $6.50B |
CCJ vs XOM vs NEE vs CVX vs COP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cameco Corporation (CCJ) | 100 | 1091.6 | +991.6% |
| Exxon Mobil Corpora… (XOM) | 100 | 322.2 | +222.2% |
| NextEra Energy, Inc. (NEE) | 100 | 146.1 | +46.1% |
| Chevron Corporation (CVX) | 100 | 199.0 | +99.0% |
| ConocoPhillips (COP) | 100 | 272.4 | +172.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCJ vs XOM vs NEE vs CVX vs COP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CCJ ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 10.9%, EPS growth 246.2%, 3Y rev CAGR 23.0%
- 9.3% 10Y total return vs COP's 233.4%
- +138.9% vs COP's +34.7%
XOM is the clearest fit if your priority is efficiency.
- 6.4% ROA vs NEE's 3.9%, ROIC 8.6% vs 4.1%
NEE has the current edge in this matchup, primarily because of its strength in growth and quality.
- 11.0% revenue growth vs CVX's -4.6%
- 29.3% margin vs CVX's 6.7%
CVX is the clearest fit if your priority is dividends.
- 3.8% yield, 8-year raise streak, vs NEE's 2.4%
COP is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 0.08, yield 2.8%
- Lower volatility, beta 0.08, Low D/E 36.4%, current ratio 1.30x
- Beta 0.08, yield 2.8%, current ratio 1.30x
- Lower P/E (13.3x vs 15.0x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.0% revenue growth vs CVX's -4.6% | |
| Value | Lower P/E (13.3x vs 15.0x) | |
| Quality / Margins | 29.3% margin vs CVX's 6.7% | |
| Stability / Safety | Beta 0.08 vs CCJ's 1.72 | |
| Dividends | 3.8% yield, 8-year raise streak, vs NEE's 2.4% | |
| Momentum (1Y) | +138.9% vs COP's +34.7% | |
| Efficiency (ROA) | 6.4% ROA vs NEE's 3.9%, ROIC 8.6% vs 4.1% |
CCJ vs XOM vs NEE vs CVX vs COP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CCJ vs XOM vs NEE vs CVX vs COP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CCJ leads in 2 of 6 categories
NEE leads 1 • COP leads 1 • XOM leads 0 • CVX leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NEE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 93.1x CCJ's $3.5B. NEE is the more profitable business, keeping 29.3% of every revenue dollar as net income compared to CVX's 6.7%. On growth, NEE holds the edge at +7.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.5B | $323.9B | $27.9B | $184.4B | $58.3B |
| EBITDAEarnings before interest/tax | $912M | $59.9B | $15.5B | $37.1B | $22.4B |
| Net IncomeAfter-tax profit | $589M | $28.8B | $8.2B | $12.3B | $7.3B |
| Free Cash FlowCash after capex | $1.1B | $23.6B | -$3.8B | $16.2B | $18.3B |
| Gross MarginGross profit ÷ Revenue | +29.4% | +21.7% | +47.8% | +30.4% | +29.2% |
| Operating MarginEBIT ÷ Revenue | +17.5% | +10.5% | +29.5% | +9.0% | +18.3% |
| Net MarginNet income ÷ Revenue | +16.9% | +8.9% | +29.3% | +6.7% | +12.6% |
| FCF MarginFCF ÷ Revenue | +30.3% | +7.3% | -13.6% | +8.8% | +31.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.4% | -1.3% | +7.3% | -5.3% | -2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +45.2% | -11.0% | +160.0% | -24.5% | -20.2% |
Valuation Metrics
COP leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 18.1x trailing earnings, COP trades at a 85% valuation discount to CCJ's 119.9x P/E. On an enterprise value basis, COP's 6.8x EV/EBITDA is more attractive than CCJ's 79.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $51.7B | $620.8B | $194.6B | $364.2B | $140.0B |
| Enterprise ValueMkt cap + debt − cash | $51.6B | $653.7B | $287.4B | $404.5B | $157.0B |
| Trailing P/EPrice ÷ TTM EPS | 119.93x | 21.86x | 28.36x | 27.53x | 18.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 74.01x | 14.79x | 23.07x | 15.02x | 13.29x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.64x | — | — |
| EV / EBITDAEnterprise value multiple | 79.53x | 10.91x | 18.73x | 10.89x | 6.77x |
| Price / SalesMarket cap ÷ Revenue | 20.26x | 1.92x | 7.08x | 1.97x | 2.38x |
| Price / BookPrice ÷ Book value/share | 10.22x | 2.37x | 2.93x | 1.76x | 2.23x |
| Price / FCFMarket cap ÷ FCF | 68.99x | 26.29x | — | 21.95x | 8.35x |
Profitability & Efficiency
CCJ leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
NEE delivers a 12.7% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $7 for CVX. CCJ carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to NEE's 1.44x. On the Piotroski fundamental quality scale (0–9), CCJ scores 8/9 vs XOM's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.8% | +10.7% | +12.7% | +7.2% | +11.3% |
| ROA (TTM)Return on assets | +6.0% | +6.4% | +3.9% | +4.2% | +6.0% |
| ROICReturn on invested capital | +6.3% | +8.6% | +4.1% | +6.2% | +10.4% |
| ROCEReturn on capital employed | +6.5% | +8.9% | +4.7% | +6.6% | +10.4% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 3 | 5 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.15x | 0.16x | 1.44x | 0.24x | 0.36x |
| Net DebtTotal debt minus cash | -$92M | $32.9B | $92.8B | $40.3B | $16.9B |
| Cash & Equiv.Liquid assets | $1.1B | $10.7B | $2.8B | $6.5B | $6.5B |
| Total DebtShort + long-term debt | $1.0B | $43.5B | $95.6B | $46.7B | $23.4B |
| Interest CoverageEBIT ÷ Interest expense | 10.04x | 69.44x | 1.99x | 17.22x | 9.42x |
Total Returns (Dividends Reinvested)
CCJ leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CCJ five years ago would be worth $59,356 today (with dividends reinvested), compared to $13,819 for NEE. Over the past 12 months, CCJ leads with a +138.9% total return vs COP's +34.7%. The 3-year compound annual growth rate (CAGR) favors CCJ at 63.0% vs COP's 7.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +20.4% | +20.3% | +16.1% | +18.2% | +19.7% |
| 1-Year ReturnPast 12 months | +138.9% | +43.9% | +42.0% | +39.5% | +34.7% |
| 3-Year ReturnCumulative with dividends | +333.3% | +44.9% | +31.0% | +26.7% | +23.7% |
| 5-Year ReturnCumulative with dividends | +493.6% | +164.6% | +38.2% | +94.0% | +131.9% |
| 10-Year ReturnCumulative with dividends | +934.7% | +105.0% | +266.0% | +135.8% | +233.4% |
| CAGR (3Y)Annualised 3-year return | +63.0% | +13.2% | +9.4% | +8.2% | +7.3% |
Risk & Volatility
Evenly matched — XOM and NEE each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than CCJ's 1.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NEE currently trades 94.5% from its 52-week high vs XOM's 83.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.72x | -0.15x | 0.21x | -0.05x | 0.08x |
| 52-Week HighHighest price in past year | $135.24 | $176.41 | $98.75 | $214.71 | $135.87 |
| 52-Week LowLowest price in past year | $47.87 | $101.19 | $63.88 | $133.77 | $84.28 |
| % of 52W HighCurrent price vs 52-week peak | +87.7% | +83.0% | +94.5% | +85.0% | +84.6% |
| RSI (14)Momentum oscillator 0–100 | 56.1 | 42.4 | 54.3 | 42.1 | 43.4 |
| Avg Volume (50D)Average daily shares traded | 3.2M | 18.9M | 8.7M | 11.0M | 9.6M |
Analyst Outlook
Evenly matched — NEE and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CCJ as "Buy", XOM as "Hold", NEE as "Buy", CVX as "Buy", COP as "Buy". Consensus price targets imply 10.6% upside for COP (target: $127) vs 4.6% for CVX (target: $191). For income investors, CVX offers the higher dividend yield at 3.76% vs CCJ's 0.15%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $125.91 | $160.43 | $98.13 | $190.93 | $127.07 |
| # AnalystsCovering analysts | 19 | 55 | 36 | 53 | 52 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +2.7% | +2.4% | +3.8% | +2.8% |
| Dividend StreakConsecutive years of raises | 2 | 26 | 30 | 8 | 1 |
| Dividend / ShareAnnual DPS | $0.24 | $4.00 | $2.24 | $6.87 | $3.19 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.3% | 0.0% | +3.3% | +3.6% |
CCJ leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). NEE leads in 1 (Income & Cash Flow). 2 tied.
CCJ vs XOM vs NEE vs CVX vs COP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CCJ or XOM or NEE or CVX or COP a better buy right now?
For growth investors, NextEra Energy, Inc.
(NEE) is the stronger pick with 11. 0% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). ConocoPhillips (COP) offers the better valuation at 18. 1x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Cameco Corporation (CCJ) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCJ or XOM or NEE or CVX or COP?
On trailing P/E, ConocoPhillips (COP) is the cheapest at 18.
1x versus Cameco Corporation at 119. 9x. On forward P/E, ConocoPhillips is actually cheaper at 13. 3x.
03Which is the better long-term investment — CCJ or XOM or NEE or CVX or COP?
Over the past 5 years, Cameco Corporation (CCJ) delivered a total return of +493.
6%, compared to +38. 2% for NextEra Energy, Inc. (NEE). Over 10 years, the gap is even starker: CCJ returned +934. 7% versus XOM's +105. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCJ or XOM or NEE or CVX or COP?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Cameco Corporation's 1. 72β — meaning CCJ is approximately -1275% more volatile than XOM relative to the S&P 500. On balance sheet safety, Cameco Corporation (CCJ) carries a lower debt/equity ratio of 15% versus 144% for NextEra Energy, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CCJ or XOM or NEE or CVX or COP?
By revenue growth (latest reported year), NextEra Energy, Inc.
(NEE) is pulling ahead at 11. 0% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: Cameco Corporation grew EPS 246. 2% year-over-year, compared to -31. 8% for Chevron Corporation. Over a 3-year CAGR, CCJ leads at 23. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CCJ or XOM or NEE or CVX or COP?
NextEra Energy, Inc.
(NEE) is the more profitable company, earning 24. 9% net margin versus 6. 7% for Chevron Corporation — meaning it keeps 24. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NEE leads at 30. 1% versus 9. 0% for CVX. At the gross margin level — before operating expenses — NEE leads at 62. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CCJ or XOM or NEE or CVX or COP more undervalued right now?
On forward earnings alone, ConocoPhillips (COP) trades at 13.
3x forward P/E versus 74. 0x for Cameco Corporation — 60. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COP: 10. 6% to $127. 07.
08Which pays a better dividend — CCJ or XOM or NEE or CVX or COP?
All stocks in this comparison pay dividends.
Chevron Corporation (CVX) offers the highest yield at 3. 8%, versus 0. 1% for Cameco Corporation (CCJ).
09Is CCJ or XOM or NEE or CVX or COP better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Cameco Corporation (CCJ) carries a higher beta of 1. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XOM: +105. 0%, CCJ: +934. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CCJ and XOM and NEE and CVX and COP?
These companies operate in different sectors (CCJ (Energy) and XOM (Energy) and NEE (Utilities) and CVX (Energy) and COP (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CCJ is a mid-cap quality compounder stock; XOM is a large-cap quality compounder stock; NEE is a mid-cap quality compounder stock; CVX is a large-cap income-oriented stock; COP is a mid-cap quality compounder stock. XOM, NEE, CVX, COP pay a dividend while CCJ does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.